跳至主要内容
临床试验/NCT06625437
NCT06625437终止不适用

Evaluation of the Effectiveness of Acceptance and Commitment Therapy for General Mental Health Concerns in HIV-Positive Men

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2025年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
Patient Health Questionnaire-9 Screener

研究概览

简要总结

The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.

详细描述

The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • identify as a man
  • be at least 18 years old
  • has been diagnosed with HIV by a healthcare professional

排除标准

  • has engaged in self-harm within the last three months
  • has attempted suicide within the last year
  • has had an active plan to attempt suicide within the last 30 days
  • is currently diagnosed with any eating disorder
  • has experienced hallucinations or delusions within the last 30 days
  • has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)

研究组 & 干预措施

Acceptance and commitment therapy

Experimental

Trial of acceptance and commitment therapy for hiv-positive men.

干预措施: Acceptance and commitment therapy (Behavioral)

结局指标

主要结局

Patient Health Questionnaire-9 Screener

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of depressive symptoms

PTSD Checklist-5

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of post-traumatic stress symptoms

Yale-Brown Obsessive Compulsive Scale

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of obsessive-compulsive disorder symptoms

Alcohol Use Disorders Identification Test

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of alcohol use

HIV stigma scale

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of facets of stigma experienced by individuals with HIV

Internalized homophobia scale

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of internalized homophobia

Brief pornography screen

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of concerning pornography use

Life Quality Scale

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of life quality

Experiential Avoidance Rating Scale

时间窗: Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of experiential avoidance

National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of drug use

High risk sexual behaviors

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

* Frequency of sex with penetration * Frequency of condom use * Frequency of oral sex * Frequency of sexual partners

Generalized Anxiety Disorder-7 Screener

时间窗: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of anxiety symptoms

PSYFLEX

时间窗: Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour)

Measure of psychological flexibility

次要结局

  • Therapeutic Alliance Scale(Administered immediately after final intervention session (8th/final session; each session is 1 hour))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicholas C. Borgogna

Assistant Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验